The Chemours Company, with stock symbol CC, is a publicly traded company on the New York Stock Exchange (NYSE). As of 3 February 2023, the company has a market capitalization of $5.4 bln. This figure is determined by multiplying the current share price (34.47) by the number of outstanding shares (148 mln). In comparison to 1 February 2023, when their market cap was $5.4 bln, this represents a slight decrease in value. However, it is much higher than its year-low on 2 May 2022 ($22.56), when their market cap was only $3.3 bln. Over the past 50 and 200 day periods, their average closing prices have been 32.61 and 33.35 respectively; indicating that despite the recent drop in price they are still representative of steady growth over the longer term period since 21 August 2022 when the 50-day average was only 28.77 and almost half of what it is today.
Looking at total shareholder return for The Chemours Company over this same time period we see an increase from 22% to 44%, suggesting investors have seen a significant return on their investment since buying into the company early last year. While it appears as though overall financial health has improved recently, analysts must also consider other variables such as debt levels and available cash reserves before providing any definitive conclusions about The Chemours Company’s financial condition at this point in time.
